Xencor, Inc.
XNCR
$12.00
$0.393.36%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
3/13/2026
-
Ticker Report
3/12/2026
-
Ticker Report
3/11/2026
-
Seeking Alpha: Transcripts
3/11/2026
-
SeekingAlpha
3/10/2026
-
Ticker Report
3/10/2026
-
MarketBeat
3/10/2026
-
MarketBeat
3/9/2026
-
Ticker Report
3/9/2026
-
MarketBeat
3/9/2026
-
MarketBeat
3/9/2026
-
MarketBeat
3/9/2026
-
MarketBeat
3/9/2026
-
MarketBeat
3/9/2026
-
MarketBeat
3/9/2026
-
TipRanks Financial Blog
3/7/2026
-
Ticker Report
3/6/2026
-
Ticker Report
3/5/2026
-
MarketBeat
3/5/2026
-
MarketBeat
3/5/2026
-
Market News Video
3/5/2026
-
Seeking Alpha - Healthcare
3/5/2026
-
Benzinga
3/5/2026
-
MarketBeat
3/5/2026
-
MarketBeat
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Wednesday, February 25, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of May 4 and 8 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
626 305 5900
Address
465 North Halstead Street
Pasadena, CA 91107
Pasadena, CA 91107
Country
Year Founded
Business Description
Sector
Xencor, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of engineered antibodies for the treatment of cancer and autoimmune diseases. The company...
more